CASE DISCUSSION

Medical Nutrition Therapy in Diabetes

Presented from India by Dr. Shruthi Bettegowda

Case Description

Medical nutrition therapy (MNT) is a cornerstone in the management of diabetes, focusing on individualized dietary plans tailored to the patient's specific needs and goals. It emphasizes a balanced intake of macronutrients, including carbohydrates, proteins, and fats, to achieve optimal blood...

Case Summary

Medical nutrition therapy (MNT), provided by dietitians or medical practitioners, is a nutrition-based treatment for illnesses and injuries. Introduced in 1994, it aims to reduce complications from pre-existing conditions like neuropathy and nephropathy, by establishing guidelines for diabetes management.

Speaker Profile

Dr. Shruthi Bettegowda

Consultant Endocrinologist, Aster G Madegowda hospital, Mandya

Dr. Shruthi Bettegowda is a highly skilled Endocrinologist with a comprehensive background in managing a wide range of endocrine disorders. With over four years of dedicated experience in the field, she has held esteemed positions as an Assistant Professor in the Department of Medicine at Adichunchanagiri Institute of Medical Sciences, Mandya, and later as an Associate Professor in the same department. Dr. Bettegowda's expertise lies in the diagnosis and management of conditions such as hyperthyroidism, hypothyroidism, PCOS, type 1 and type 2 diabetes, and gestational diabetes. She is committed to providing personalized care to her patients, utilizing her extensive knowledge and clinical skills to optimize treatment outcomes and improve overall patient well-being. Currently serving as an Assistant Professor in the Department of Endocrinology and Metabolism at SVIMS, Tirupati, Dr. Bettegowda continues to contribute significantly to the field of endocrinology through her clinical expertise and academic pursuits.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.